• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群的研究:预测膀胱癌伴有印戒细胞癌患者总生存期的模型。

A model for predicting overall survival in bladder cancer patients with signet ring cell carcinoma: a population-based study.

机构信息

Department of Urology, Prostate & Andrology Key Laboratory of Baoding, Baoding No. 1 Central Hospital, No. 320 Changcheng North Street, Lianchi District, Baoding, 071000, Hebei, China.

出版信息

Eur J Med Res. 2023 Feb 2;28(1):61. doi: 10.1186/s40001-022-00970-y.

DOI:10.1186/s40001-022-00970-y
PMID:36732873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9893594/
Abstract

INTRODUCTION

This study is to examine the predictors of survival and to construct a nomogram for predicting the overall survival (OS) of primary bladder signet ring cell carcinoma (SRCC) patients based on the analysis of the Surveillance, Epidemiology, and End Results (SEER) database.

METHODS

A total of 219 eligible patients diagnosed with SRCC were analyzed using the 2004-2015 data from SEER database. Univariate and multivariate Cox regression were used to determine independent prognostic factors, followed by development of a nomogram based on the multivariate Cox regression models. The consistency index (C-index), receiver operating characteristic (ROC) curve, and calibration curve were used to validate the prognostic nomogram.

RESULTS

The nomograms indicated appreciable accuracy in predicting the OS, with C-index of 0.771 and 0.715, respectively. The area under the curve (AUC) of the nomogram was 0.713 for 1 year, 0.742 for 3 years, and 0.776 for 5 years in the training set, while was 0.730 for 1 year, 0.727 for 3 years, and 0.697 for 5 years in the validation set. The calibration curves revealed satisfactory consistency between the prediction of deviation correction and ideal reference line.

CONCLUSIONS

The prognostic nomogram developed in the analytical data of SEER it provided high accuracy and reliability in predicting the survival outcomes of primary bladder SRCC patients and could be used to comprehensively assess the risk of SRCC. Moreover, they could enable clinicians to make more precise treatment decisions for primary bladder SRCC patients.

摘要

简介

本研究旨在探讨影响生存的预测因素,并基于 SEER 数据库的分析,构建一个列线图来预测原发性膀胱印戒细胞癌(SRCC)患者的总生存期(OS)。

方法

共分析了 219 例符合条件的 SRCC 患者,这些患者的数据来自 SEER 数据库 2004-2015 年的资料。采用单因素和多因素 Cox 回归分析确定独立的预后因素,然后根据多因素 Cox 回归模型构建列线图。一致性指数(C 指数)、接收者操作特征(ROC)曲线和校准曲线用于验证预测列线图的准确性。

结果

列线图在预测 OS 方面具有相当高的准确性,C 指数分别为 0.771 和 0.715。在训练集中,列线图的曲线下面积(AUC)分别为 1 年时 0.713、3 年时 0.742 和 5 年时 0.776,在验证集中,AUC 分别为 1 年时 0.730、3 年时 0.727 和 5 年时 0.697。校准曲线显示了预测偏差校正与理想参考线之间的良好一致性。

结论

在 SEER 分析数据中开发的预后列线图在预测原发性膀胱 SRCC 患者的生存结果方面具有较高的准确性和可靠性,可以用于全面评估 SRCC 的风险。此外,它们可以使临床医生为原发性膀胱 SRCC 患者做出更精确的治疗决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5637/9893594/d0ac0ff4b885/40001_2022_970_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5637/9893594/7510703a0e81/40001_2022_970_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5637/9893594/0a739612c529/40001_2022_970_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5637/9893594/845e26b19340/40001_2022_970_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5637/9893594/d121acc884a4/40001_2022_970_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5637/9893594/23ba85f023a9/40001_2022_970_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5637/9893594/d0ac0ff4b885/40001_2022_970_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5637/9893594/7510703a0e81/40001_2022_970_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5637/9893594/0a739612c529/40001_2022_970_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5637/9893594/845e26b19340/40001_2022_970_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5637/9893594/d121acc884a4/40001_2022_970_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5637/9893594/23ba85f023a9/40001_2022_970_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5637/9893594/d0ac0ff4b885/40001_2022_970_Fig6_HTML.jpg

相似文献

1
A model for predicting overall survival in bladder cancer patients with signet ring cell carcinoma: a population-based study.基于人群的研究:预测膀胱癌伴有印戒细胞癌患者总生存期的模型。
Eur J Med Res. 2023 Feb 2;28(1):61. doi: 10.1186/s40001-022-00970-y.
2
A prognostic framework for predicting lung signet ring cell carcinoma via a machine learning based cox proportional hazard model.基于机器学习的 Cox 比例风险模型预测肺印戒细胞癌的预后框架。
J Cancer Res Clin Oncol. 2024 Jul 25;150(7):364. doi: 10.1007/s00432-024-05886-0.
3
Nomograms to predict individual prognosis of patients with primary signet ring cell carcinoma of the urinary bladder.预测原发性膀胱印戒细胞癌患者个体预后的列线图。
Transl Cancer Res. 2021 Sep;10(9):3948-3962. doi: 10.21037/tcr-21-929.
4
A novel log odds of positive lymph nodes-based nomogram for predicting overall survival in patients with colorectal signet ring cell carcinoma: a SEER population-based study.一种基于淋巴结阳性对数比的新型列线图预测结直肠印戒细胞癌患者总生存的研究:一项 SEER 人群研究。
Int J Colorectal Dis. 2024 Apr 1;39(1):44. doi: 10.1007/s00384-024-04622-x.
5
Clinicopathologic and prognostic factors of patients with T3/T4 colorectal signet ring cell carcinoma: a population-based study.T3/T4 结直肠印戒细胞癌患者的临床病理和预后因素:一项基于人群的研究。
J Cancer Res Clin Oncol. 2023 Sep;149(12):9747-9756. doi: 10.1007/s00432-023-04880-2. Epub 2023 May 28.
6
Clinical features and prognostic factors of esophageal signet ring cell carcinoma: construction and validation of a model based on the SEER database.食管印戒细胞癌的临床特征及预后因素:基于监测、流行病学与最终结果(SEER)数据库构建并验证模型
Transl Cancer Res. 2022 Oct;11(10):3674-3685. doi: 10.21037/tcr-22-1238.
7
Prognostic nomograms for predicting overall survival and cause-specific survival of signet ring cell carcinoma in colorectal cancer patients.预测结直肠癌患者印戒细胞癌总生存期和特定病因生存期的预后列线图。
World J Clin Cases. 2021 Apr 16;9(11):2503-2518. doi: 10.12998/wjcc.v9.i11.2503.
8
Development and validation of a novel nomogram for postoperative overall survival of patients with primary gastric signet-ring cell carcinoma: a population study based on SEER database.基于 SEER 数据库的人群研究:开发和验证原发性胃印戒细胞癌患者术后总生存的新型列线图
J Cancer Res Clin Oncol. 2023 Sep;149(11):8593-8603. doi: 10.1007/s00432-023-04796-x. Epub 2023 Apr 25.
9
Prognostic Nomograms for Patients with Primary Sarcomatoid Carcinoma of The Urinary Bladder: Based on The SEER Database.基于 SEER 数据库的原发性膀胱肉瘤样癌患者预后列线图
Urol J. 2024 Mar 24;21(2):87-97. doi: 10.22037/uj.v20i.7595.
10
A Prognostic Model for Survival in Patients with Gastric Signet Ring Cell Carcinoma.胃印戒细胞癌患者生存预后模型。
Dig Dis. 2024;42(3):221-229. doi: 10.1159/000536454. Epub 2024 Feb 9.

引用本文的文献

1
Oncological outcome and survival predictors of widowed patients with bladder cancer in special populations.特殊人群中丧偶膀胱癌患者的肿瘤学结局及生存预测因素
Sci Rep. 2025 Aug 20;15(1):30638. doi: 10.1038/s41598-025-13033-z.
2
A predictive and prognostic model for metastasis risk and prognostic factors in gastrointestinal signet ring cell carcinoma.预测和预后模型用于胃肠道印戒细胞癌的转移风险和预后因素。
Eur J Med Res. 2024 Nov 14;29(1):545. doi: 10.1186/s40001-024-02135-5.
3
Treatment Options for Signet Ring Cell Carcinoma of the Urinary Bladder: A Population-Based Study.

本文引用的文献

1
Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors.在尿路上皮癌的新辅助治疗环境中出现的新治疗机会:分子分类和免疫检查点抑制剂开辟的新前景。
Int J Mol Sci. 2022 Jan 20;23(3):1133. doi: 10.3390/ijms23031133.
2
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy.中性粒细胞与白蛋白比值可预测接受新辅助化疗后行根治性膀胱切除术的膀胱癌患者的死亡率。
Future Sci OA. 2021 Apr 20;7(7):FSO709. doi: 10.2144/fsoa-2021-0008. eCollection 2021 Aug.
3
治疗膀胱癌印戒细胞癌的选择:一项基于人群的研究。
Cancer Control. 2024 Jan-Dec;31:10732748241278485. doi: 10.1177/10732748241278485.
4
Development and validation of a novel nomogram model for predicting the survival of patients with T2-4a, N0-x, M0 bladder cancer: a retrospective cohort study.一种用于预测T2-4a、N0-x、M0期膀胱癌患者生存率的新型列线图模型的开发与验证:一项回顾性队列研究
Am J Clin Exp Urol. 2023 Dec 15;11(6):500-515. eCollection 2023.
Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future.
新辅助免疫治疗在膀胱癌中的最新进展:近期内的展望。
Cancer Treat Rev. 2021 Feb;93:102142. doi: 10.1016/j.ctrv.2020.102142. Epub 2021 Jan 5.
4
Pelvic Lymph Node Dissection During Cystectomy for Patients With Bladder Carcinoma With Variant Histology: Does Histologic Type Matter?组织学类型变异的膀胱癌患者膀胱切除术中盆腔淋巴结清扫:组织学类型有影响吗?
Front Oncol. 2020 Oct 19;10:545921. doi: 10.3389/fonc.2020.545921. eCollection 2020.
5
Signet-Ring Cell Carcinoma as an Independent Prognostic Factor for Patients With Urinary Bladder Cancer: A Population-Based Study.印戒细胞癌作为膀胱癌患者的独立预后因素:一项基于人群的研究。
Front Oncol. 2020 May 15;10:653. doi: 10.3389/fonc.2020.00653. eCollection 2020.
6
What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review.膀胱癌的尿路上皮和非尿路上皮组织学变异对肌层浸润性和转移性膀胱癌患者的肿瘤学结局的预测价值及临床重要性如何?欧洲泌尿外科学会肌层浸润性和转移性膀胱癌指南小组系统评价。
Eur Urol Oncol. 2019 Nov;2(6):625-642. doi: 10.1016/j.euo.2019.09.003. Epub 2019 Oct 8.
7
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.肌肉浸润性膀胱癌的共识分子分类。
Eur Urol. 2020 Apr;77(4):420-433. doi: 10.1016/j.eururo.2019.09.006. Epub 2019 Sep 26.
8
Primary signet-ring cell carcinoma of the urinary bladder: A report of two cases.膀胱原发性印戒细胞癌:2例报告
Tunis Med. 2019 Jan;97(1):167-169.
9
An updated review on primary signet-ring cell carcinoma of the urinary bladder and report of a case.膀胱原发性印戒细胞癌的最新综述及病例报告
Scand J Urol. 2018 Apr;52(2):87-93. doi: 10.1080/21681805.2017.1418020. Epub 2018 Jan 1.
10
Primary Signet-Ring Cell Carcinoma of the Urinary Bladder Successfully Managed with Radical Cystectomy in a Young Patient.一名年轻患者原发性膀胱印戒细胞癌经根治性膀胱切除术成功治疗。
Case Rep Urol. 2017;2017:9121078. doi: 10.1155/2017/9121078. Epub 2017 Jun 5.